CollPlant Biotechnologies (CLGN) Free Cash Flow (2018 - 2026)

CollPlant Biotechnologies has reported Free Cash Flow for 9 years, with the latest figure at -$3.0 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow fell 162.78% year-over-year to -$3.0 million; the trailing twelve-month figure through Mar 2026 stood at -$11.3 million (up 2.77% YoY), and the FY2025 full-year result was -$9.4 million, up 31.0% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$3.0 million, down from -$2.9 million in the prior quarter.
• The five-year high for Free Cash Flow was $7.0 million in Q3 2023, with the low at -$12.4 million in Q4 2022.
• Historically, Free Cash Flow has averaged -$2.9 million across 5 years, with a median of -$3.0 million in 2026.
• Annual changes were most pronounced in 2022 — Free Cash Flow sank 1152.42% — and 2023, when it soared 344.05%.
• CollPlant Biotechnologies' Free Cash Flow stood at -$12.4 million in 2022, then jumped by 82.97% to -$2.1 million in 2023, then sank by 60.92% to -$3.4 million in 2024, then climbed by 14.24% to -$2.9 million in 2025, then slipped by 4.21% to -$3.0 million in 2026.
• The last three Free Cash Flow figures came in at -$3.0 million (Q1 2026), -$2.9 million (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.